Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

85 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evaluation of a Meropenem and Piperacillin Monitoring Program in Intensive Care Unit Patients Calls for the Regular Assessment of Empirical Targets and Easy-to-Use Dosing Decision Tools.
Weinelt FA, Stegemann MS, Theloe A, Pfäfflin F, Achterberg S, Weber F, Dübel L, Mikolajewska A, Uhrig A, Kiessling P, Huisinga W, Michelet R, Hennig S, Kloft C. Weinelt FA, et al. Among authors: huisinga w. Antibiotics (Basel). 2022 Jun 2;11(6):758. doi: 10.3390/antibiotics11060758. Antibiotics (Basel). 2022. PMID: 35740164 Free PMC article.
Impact of altered endogenous IgG on unspecific mAb clearance.
Fuhrmann S, Kloft C, Huisinga W. Fuhrmann S, et al. Among authors: huisinga w. J Pharmacokinet Pharmacodyn. 2017 Aug;44(4):351-374. doi: 10.1007/s10928-017-9524-2. Epub 2017 Apr 24. J Pharmacokinet Pharmacodyn. 2017. PMID: 28439684
Role of renal function in risk assessment of target non-attainment after standard dosing of meropenem in critically ill patients: a prospective observational study.
Ehmann L, Zoller M, Minichmayr IK, Scharf C, Maier B, Schmitt MV, Hartung N, Huisinga W, Vogeser M, Frey L, Zander J, Kloft C. Ehmann L, et al. Among authors: huisinga w. Crit Care. 2017 Oct 21;21(1):263. doi: 10.1186/s13054-017-1829-4. Crit Care. 2017. PMID: 29058601 Free PMC article. Clinical Trial.
Absence of Relationship Between Crohn's Disease Activity Index or C-Reactive Protein and Infliximab Exposure Calls for Objective Crohn's Disease Activity Measures for the Evaluation of Treatment Effects at Treatment Failure.
Edlund H, Grisic AM, Steenholdt C, Ainsworth MA, Brynskov J, Huisinga W, Kloft C. Edlund H, et al. Among authors: huisinga w. Ther Drug Monit. 2019 Apr;41(2):235-242. doi: 10.1097/FTD.0000000000000590. Ther Drug Monit. 2019. PMID: 30883516 Clinical Trial.
Comment on Jaki et al., A proposal for a new PhD level curriculum on quantitative methods for drug development. Pharmaceutical Statistics 17 (5):593-606, Sep/Oct 2018, DOI: 10.1002/pst.1873.
Krause A, Kloft C, Huisinga W, Karlsson M, Pinheiro J, Bies R, Rogers J, Mentré F, Musser BJ; ASA Special Interest Group on Statistics and Pharmacometrics/ASA Special Interest Group on Statistics and Pharmacometrics (SIG SxP). Krause A, et al. Among authors: huisinga w. Pharm Stat. 2019 May;18(3):278-281. doi: 10.1002/pst.1940. Epub 2019 Apr 1. Pharm Stat. 2019. PMID: 30932340 No abstract available.
85 results